Hyperglycemia in patients with type 2 diabetes causes multiple neuronal complications, e.g., diabetic polyneuropathy, cognitive decline, and embryonic neural crest defects due to increased apoptosis. Possible mechanisms of neuronal response to increased glucose burden are still a matter of debate. Insulin and insulinlike growth factor-1 (IGF-1) receptor signaling inhibits glucose-induced caspase-3 activation and apoptotic cell death. The insulin receptor substrates (IRS) are intracellular adapter proteins mediating insulin's and IGF-1's intracellular effects. Even though all IRS proteins have similar function and structure, recent data suggest different actions of IRS-1 and IRS-2 in mediating their anti-apoptotic effects in glucose neurotoxicity. We therefore investigated the role of IRS-1/-2 in glucose-induced caspase-3 activation using human neuroblastoma cells. Overexpression of IRS-1 or IRS-2 caused complete resistance to glucose-induced caspase-3 cleavage. Inhibition of PI3-kinase reversed this protective effect of IRS-1 or IRS-2. However, MAPkinases inhibition had only minor impact. IRS overexpression increased MnSOD abundance as well as BAD phosphorylation while Bim and BAX levels remained unchanged. Since Akt promotes cell survival at least partially via phosphorylation and inhibition of downstream forkhead box-O (FoxO) transcription factors, we generated neuroblastoma cells stably overexpressing a dominant negative mutant of FoxO1 mimicking activation of the insulin/IGF-1 pathway on FoxO-mediated transcription. Using these cells we showed that FoxO1 is not involved in neuronal protection mediated by increased IRS-1/-2 expression. Thus, overexpression of both IRS-1 and IRS-2 induces complete resistance to glucose-induced caspase-3 activation via PI3-kinase mediated BAD phosphorylation and MnSOD expression independent of FoxO1.
Introduction
Hyperglycemia in type 2 diabetes causes an up to four-fold increase of intracellular glucose concentration in neurons. If persistent or frequently occurring, this glucose challenge leads to neuronal damage often referred to as glucose neurotoxicity (review in [1] ). The pathological correlate of long term glucose neurotoxicity in patients presents as diabetic neuropathy varying from mild paresthesia to complete loss of sensibility. Diabetic neuropathy is the leading cause for diabetic foot syndrome with ulcers, chronic non-healing lesions, osteomyelitis and diabetic osteoarthropathy frequently resulting in amputations. Investigation of different model organisms suggests that hyperglycemia-induced caspase-3 activation is involved in the pathogenesis of diabetic neuropathy even if the degree of caspase-3 activation does not lead to lethal damage of dorsal root ganglia cells [2] [3] [4] [5] [6] [7] . Not less severely presents neuronal apoptosis induced by hyperglycemia in pregnant women suffering from uncontrolled diabetes leading to neural crest defects inducing embryonal death or severe disability of the newborn child [8] .
Most authors so far favor oxidative stress as molecular mechanism for glucose neurotoxicity, which is promoted by glucose through a combination of increased free-radical production and impaired freeradical clearance. In case of hyperglycemia glucose is not only metabolized via glycolysis but also via the polyol pathway affecting the glutathione cycle by exhausting NADPH [9, 10] . This decreases the capacity of glutathione peroxidase to metabolize hydrogen peroxide [11] .
Insulin receptor (IR) and insulin-like growth factor (IGF)-1 receptor (IGF-1R) signaling has been shown to inhibit glucose-induced caspase-3 activation and neuronal apoptosis [12] . IR and IGF-1R transmit their intracellular signaling via so called insulin receptor substrates (IRS). The mammalian IRS protein family has at least four members, IRS-1 to IRS-4, which are characterized by an N-terminal pleckstrin homology (PH) domain, a phosphotyrosine-binding (PTB) domain as well as a C-terminal tail containing multiple tyrosine phosphorylation sites (review in [13] ). IRS-1, IRS-2, and IRS-4 are expressed in mice as well as in humans, IRS-3 is exclusively found in rodent adipose tissue [14] . Upon activation the IRS proteins bind several SH 2 domain-containing signaling proteins, such as the regulatory subunit of phosphatidylinositol-3-kinase (PI3K), growth factor receptor binding protein (GRB)-2, and SH 2 -phosphatase (SHP)-2. Activation of PI3K results in phosphorylation of PtdIns (phosphatidylinositols) to generate PtdIns-triphosphate (PtdIns-3,4,5-P). This leads to an activation of several downstream targets, such as phosphoinositidedependent protein kinase (PDK)-1/-2, protein kinase B (PKB, also known as Akt), and inhibition of glycogen synthase kinase-3β (GSK-3β). Furthermore, Akt phosphorylates the forkhead transcription factor FoxO1, which triggers its nuclear exclusion and thereby regulates transcription [15, 16] .
Activation of the PI3K/Akt cascade promotes neuronal growth and survival by phosphorylating FoxO-transcription factors to regulate gene transcription (e.g., FAS ligand) and phosphorylating Bcl-2-associated death promoter/anti-Bcl-2 antagonist of cell death (BAD) protein [17] [18] [19] . Furthermore, IGF-1 suppresses Bim expression via the PI3K and the MAP-kinase (MAPK) pathways to inhibit apoptosis [20] . Akt also inactivates GSK-3β, which promotes cellular metabolism, proliferation, and survival [21] .
So far the only study dealing with the role of IRS proteins in mediating the antiapoptotic effect of insulin and IGF-1 in the context of glucose neurotoxicity suggests that IRS-2 but not IRS-1 mediates insulin's and IGF-1's antiapoptotic effects [22] .
In order to further dissect the role of IRS-1 and IRS-2 as mediators of neuronal response to glucose challenge we generated human neuroblastoma cells overexpressing either IRS-1 or IRS-2. Here we show that IRS-1 and IRS-2 overexpression induces resistance to glucose-induced caspase-3 activation via PI3K mediated BAD phosphorylation and increased MnSOD expression independent of FoxO1.
Materials and methods

Generation of stable cell lines
IRS-1 was amplified from cDNA using the following primers: 5′-AAGTCGACGAATTCGCATGGCGAGCCCTCCGGAGAGCGAT-3′ and 5′-GATCTA GAAAGCTTCTACTGACGGTCCTCTGGCTGCTTCTG-3′. The PCR fragment was cloned into the eukaryotic expression vector pCMV-Tag 2C (Stratagene) using EcoRI and HindIII. IRS2 was amplified using 5′-CGGGATCCTGATGGCTAGCGCGCC-3′ and 5′-GGAATTCTCACTCTTTCAC-GACTG-3′ as primers. The final product was ligated BamHI/EcoRI into pCMV-Tag 2C. Foxo-DN was cloned using 5′-AAAGGATC CGCCAC-CATGGCCGAAGCGCCCCAGGTGGT-3′ as forward and 5′-AAACTCGAG GTCCATGGACGCAGCTCTTCTCCG-3′ as reverse primer. Final product was ligated XhoI/BamHI into pCMV-Tag 2C for eukaryotic expression. As a control cell line, we transfected SHSY5Y cells with the pCMV-Tag 2C vector without insert (empty vector; EV). To achieve stable transfection of SHSY5Y neuroblastoma cells, constructs were linearized before with MluI (Fermentas). All cells were transfected using Effectene (Qiagen) according to the manufacturer's instructions. Selection of successfully transfected cells was started after 72 h using DMEM with 1 mg/ml G418 (Sigma). After 1 week of selection single clones were picked and transferred into 96-well plates (Greiner-bio-one) using DMEM with 1 mg/ml G418. Afterwards, cells were harvested and tested for IRS-1, IRS-2 and FoxODN protein expression by Western blot, respectively. In case of siRNA expression, pSuppressorNeo vector system containing the appropriate siRNA [23] was used.
Cell culture
SHSY5Y cells were maintained in DMEM (Gibco) containing GlutaMAX-I, 4.5 g/l D-glucose (or as indicated for the particular experiment) and sodium pyruvate, supplemented with 10% FCS and were grown at 37°C with 5% CO 2 . Glucose (Roth) or mannitol (Sigma) in final concentrations of 10, 100 and 250 mM were used in the described experiments. For stimulation with IGF-1 (Sigma) or insulin (Sigma) we used final concentrations of 1, 10 and 100 nM, respectively. 50 μM PD98,059 (Sigma) was used for MEK pathway and 20 μM LY294002 (Calbiochem) for PI3-kinase inhibition. Since both inhibitors are dissolved in DMSO (Sigma), we treated control cells with the same volume of DMSO without inhibitors to exclude solvent effects.
Immunoblotting
Cells were lysed in cell lysis buffer [10 mM Tris-HCl (pH 7.4)], 1% Triton X-100, 10 mM EDTA, 50 mM NaCl, 50 mM NaF, 2 mM NaVO 3 , 1 mM PMSF and 0,1 μg/ml aprotinine). 
Immunoprecipitation
Immunoprecipitation was performed by incubating 1 mg protein lysate overnight at 4°C on an overhead shaker using anti-FLAG-M2-antibody coupled agarose beads (Sigma). Samples were washed three times with PBS, resuspended in 4× SDS sample buffer (250 mM TrisHCl (pH 6.8), 200 mM DTT, 8% SDS, 0.04% bromphenol-blue, 40% glycerol) and analyzed by Western blotting using anti-IRS-1 or anti-IRS-2 for detection.
Real time PCR
For real time PCR, we isolated RNA from cells using RNeasy Mini Kit (Qiagen). cDNA synthesis was performed with the SuperScript VILO cDNA synthesis kit (Invitrogen) according to the manufacturer's instructions. To determine mRNA levels, a TaqMan assay was performed on a Step One Plus real time PCR system (Applied Biosystems) using IRS-1 (Hs00178563_m1) and IRS2 (Hs00275843_s1) as probes (Applied Biosystems). For endogenous control we used an 18 s eukaryotic rRNA (4319413E) probe. Relative gene expression was quantified using the ΔΔCt method.
Results
Generation of IRS-1 and IRS-2 overexpressing human neuroblastoma cell lines
For generation of cell lines stably overexpressing IRS-1 or IRS-2, neuroblastoma cells (SHSY5Y) were used. The cDNA coding for either IRS-1 or IRS-2 was cloned into pCMV-Tag 2C. Linearized vector was transfected using Effectene (Qiagen) according to the manufacturer's instructions. As controls, SHSY5Y cells were transfected with the empty vector construct (EV). Two days after transfection, cells were treated with selection medium containing 1 mg/ml G418 (Sigma). After 3 weeks of selection, single cells were separated on 96-well plates. Clones which were grown from these single cells were tested for expression of the particular IRS-gene, and positive clones were selected for further experiments. The cells used for experiments were grown without G418. In order to visualize successful transfection of full length cDNA of either IRS-1 or IRS-2 we used the T3-, T7-primers for PCR ( Supplementary Fig. 1 ). PCR with these primers revealed the expected PCR-product size for FLAG-IRS-1, FLAG-IRS-2, and EV. RT-PCR of IRS-1 and IRS-2 showed an approximately 1.7-fold increase of IRS-1 mRNA in IRS-1 overexpressing cells with unchanged IRS-2 mRNA expression compared to EV and untransfected SHSY5Y cells ( Fig. 1A and B) . mRNA of IRS-2 was approximately 1.5-fold higher in FLAG-IRS-2 overexpressing cells compared to EV and SHSY5Y cells (Fig. 1B) . IRS-1 mRNA concentrations did not change in IRS-2 overexpressing cells ( Fig. 1A and B) . Immunoprecipitation using anti-FLAG-antibodycoupled agarose beads revealed remarkable expression of FLAG-IRS-1 and FLAG-IRS-2 in the accordingly transfected cells (Fig. 1C) . Western blots for IRS-1 and IRS-2 showed indeed that FLAG-IRS-2 overexpressing cells largely overexpress IRS-2 without changes in IRS-1-expression (Fig. 1D ). In turn, IRS-1 was far overexpressed in FLAG-IRS-1 expressing cells, again without any changes of IRS-2-expression (Fig. 1D) . The experiments proved successful generation of IRS-1 and IRS-2 overexpressing cells. Three different clones of either IRS-1 or IRS-2 overexpressing cells were selected for further experiments. All experiments reported here were repeated at least in two different clones of IRS-1 and IRS-2 overexpressing cells.
Since we aimed to study the effect of IRS-1/-2 overexpression on glucose-induced stress we measured expression of glucose transporter 3 (GLUT3), the most important glucose transporter in neurons. Western blots using GLUT3 specific antibodies revealed no changes in GLUT3 expression between the different clones as well as between IRS-1, IRS-2, EV and untransfected SHSY5Y cells (Fig. 1E ) excluding artifacts due to altered glucose transport between the different cell lines.
IR/IGF-1R signaling is increased in IRS-1 and IRS-2 overexpressing cells
To investigate downstream signaling, we used 3 different clones of IRS-1 and IRS-2 overexpressing cells and measured expression and phosphorylation of important kinases of the IR/IGF-1R signaling cascade. We found no changes in Akt and Erk-1/-2 expression in our cell lines without any difference between the three individual clones per group or between IRS-1 and IRS-2-overexpressing cells (Fig. 1E) . Furthermore, we did not find any changes of GSK-3β, IR, and IGF-1R expression under conditions of IRS-1 or IRS-2 overexpression compared to EV and untransfected SHSY5Y cells and between IRS-1 and IRS-2 cells (data not shown). To analyze variation in the expression of Erk and Akt in the cell lines we quantified expression of these proteins in our signaling experiments using actin expression as loading control (Supplementary Fig. 2) . These experiments exclude changes in Erk/Akt protein expression influencing the quantification of phospho/total Erk and Akt ratios.
Glucose challenge does not alter IGF-1-induced Akt phosphorylation
Recent data suggest a distinct role of IRS-1 and IRS-2 to inhibit glucose-induced caspase-3 activation [22] . According to these data, IRS-1 undergoes rapid caspase-mediated degradation in the presence of high glucose levels. However, hyperglycemia-mediated IRS-2 degradation occurs slowly and is blocked by proteasome and calpain inhibitors possibly explaining why IRS-2, but not IRS-1 rescues glucose-induced caspase-3 activation and apoptosis in this study [22] . To investigate whether glucose treatment had any influence on IGF-1-induced Akt phosphorylation we treated serum starved cells with glucose for 6 h, stimulated the cells with 10 nM IGF-1 for 5 min, and performed Western blots to visualize Akt phosphorylation at Ser 473 . Glucose treatment had no influence on basal Akt phosphorylation in any cell type (Fig. 3) . As expected, IGF-1-stimulated Akt phosphorylation was increased in IRS-1 and IRS-2 overexpressing cells compared to EV even under high glucose conditions (Fig. 3) . However, there were no differences in IGF-1-stimulated Akt phosphorylation in IRS-1 or IRS-2 overexpressing cells following 250 mM glucose treatment excluding relevant IGF-1 resistance due to rapid IRS-1 degradation in any cell type (Fig. 3 , see also Fig. 7A ).
IRS-1 and IRS-2 overexpression rescues glucose-induced caspase-3 activation
To investigate the role of IRS-1 and IRS-2 in the context of glucoseinduced caspase-3 activation we treated serum starved EV, untransfected SHSY5Y, IRS-1 and IRS-2 overexpressing cells with 0, 10, 100, and 250 mM glucose. In order to detect any influence of glucoseunspecific osmotic artifacts we used mannitol-treated cells (0, 10, 100, 250 mM) as controls. As described previously, we found that glucose treatment induced robust caspase-3 activation between 100 and 250 mM glucose in untransfected SHSY5Y cells (Fig. 4A and B ) [22] . Treatment with increasing doses of glucose in either IRS-1 or IRS-2 overexpressing cells did not induce detectable caspase-3 cleavage, suggesting that IRS-1 as well as IRS-2 overexpression rescues glucose induced caspase-3 activation (Fig. 4C-F) . Differences in caspase-3 cleavage between the IRS-1 or IRS-2 overexpressing cells or the different clones of IRS protein overexpressing cells were not observed ( Fig. 4E and F) . Thus, IRS-1 and IRS-2 overexpression rescues glucose induced caspase-3 activation in SHSY5Y neuroblastoma cells similarly. In most experiments, mannitol did not induce any detectable caspase-3 cleavage. However, in some experiments we observed a caspase-3 activation in mannitol treated cells independent of the cell type used (for example Fig. 4C and D) suggesting that under certain circumstances (glucose unspecific) osmotic stress might have an influence even in concentrations about 100-250 mM.
To reinforce the role of IRS proteins in the context of glucose neurotoxicity we used a siRNA approach to stably downregulate IRS-2 expression in SHSY5Y neuroblastoma cells, leading to about 75% downregulation of IRS-2 ( Supplementary Fig. 3) . Surprisingly, we observed an increased basal Akt activation in IRS-2 siRNA cells compared to SHSY5Y cells at least partially due to compensation via IRS-1 expression especially under conditions of serum starvation. Because of this compensatory mechanism our knockdown approach was not helpful to distinguish between the function of the different IRS proteins at least in SHSY5Y neuroblastoma cells.
IRS protein-mediated inhibition of caspase-3 activation is PI3K dependent
As suggested by previous studies, we tested whether IGF-1 is capable to inhibit glucose-induced caspase-3 activation. Therefore, we treated serum starved EV cells with 250 mM glucose for 6 h with and without 10 nM IGF-1 stimulation. IGF-1 treatment completely blocked glucose-induced caspase-3 cleavage, reinforcing the importance of IGF-1 signaling in this context (Fig. 5A) . To elucidate the role of the different IRS-activated signaling pathway proteins possibly mediating the inhibition of glucose-induced caspase-3 activation we used inhibitors of the PI3K (LY294002) and MAPK pathway (MEK-1 inhibitor: PD98,059). As shown in our previous experiments, glucose treatment of EV cells caused robust caspase-3 activation (Fig. 5B) . Neither LY294002 (20 μM final concentration) nor PD98,059 (50 μM final concentration) treatment had any effect on glucose-induced caspase-3 cleavage in EV cells, suggesting that under basal conditions PI3K and MAPK do not inhibit caspase-3 activation (Fig. 5B) . As described above, IRS-1 and IRS-2 overexpressing cells are, even under basal conditions (serum starved, no IGF-1 treatment), completely protected against glucose-induced caspase-3 activation (Fig. 5C   Fig. 2 . IGF-1 signaling is increased in IRS-1 and IRS-2 overexpressing cells. Cells of the different cell lines were cultured in DMEM and 10% FCS to 80% confluence. Prior to IGF-1 stimulation cells were serum starved overnight. For IGF-1 treatment 0, 1, 10, 100 nM IGF-1 were applied for 5 min. After IGF-1 stimulation cells were lysed and SDS-PAGE and Western blots were performed as described in Materials and methods. Antibodies against pAkt Ser473 , Akt, Erk-1/-2 and pErk-1/-2 Thr202/204 were used. To quantify changes in optical density, we used the software AIDA 4.00.027 (Raytest, Straubenhardt, Germany). Results were expressed as fold increase compared to untreated EV cells. and D). Interestingly, inhibition of the PI3K pathway counteracts the effect of IRS-1 and IRS-2 overexpression. However, it should be noted that the MEK1 inhibitor PD98,059 had a minor but still reproducible effect ( Fig. 5C and D) . Taken together, in case of glucose neurotoxicity IRS-proteins mediate their protective effect mainly via the PI3K pathway. 
Bim expression is not responsible for IRS-1 or IRS-2 mediated effects on glucose neurotoxicity
One mechanism how IGF-1 mediates its anti-apoptotic effects is the rapid regulation of the pro-apoptotic factor Bim. In other cell types it has been reported that the PI3K and the MAPK pathway, activated by IGF-1, suppress Bim expression via transcriptional, posttranslational and/or epigenetic mechanisms [20] . We investigated Bim expression under basal conditions and after treatment with MEK-1 and PI3K inhibitors. Interestingly, there were no significant differences in basal BimEL, BimL and BimS expression between EV, IRS-1 or IRS-2 overexpressing cells (Fig. 6A) . PI3K inhibition increased BimEL, BimL and BimS expression in all cell types similarly (Fig. 6A) , excluding suppressed Bim expression as molecular mechanism for the protective effect of IRS-1/-2. However, at least in EV cells MEK-1 inhibition by PD98,059 had no influence on Bim expression (Fig. 6A) .
BAD phosphorylation is increased due to IRS-1 and IRS-2 overexpression
Bcl-2-associated death promoter (BAD) protein is a pro-apoptotic member of the Bcl-2 family. Unphosphorylated BAD forms heterodimers with the anti-apoptotic factors Bcl-2 or Bcl-xL allowing BAX to trigger apoptosis. It has been described that activation of the PI3K/Akt cascade promotes survival by activation and phosphorylation of BAD at Ser 136 [17, 18, 24] . Upon phosphorylation, BAD binds 14-3-3 leaving
Bcl-2 free to inhibit BAX-triggered apoptosis. We therefore investigated BAD expression and BAD Ser136 phosphorylation in our newly generated cell lines. BAD concentrations were unaltered in all cell types (Fig. 6B) without any difference between EV and untransfected SHSY5Y as well as between the three different clones of IRS-1 and IRS-2 overexpressing cells used in the present study. Interestingly, IRS-1 and IRS-2 overexpressing cells showed remarkably increased basal BAD phosphorylation at Ser 136 (Fig. 6B ) in all three different clones of each cell type compared to EV and untransfected SHSY5Y cells suggesting that elevated BAD phosphorylation is one of the mechanisms how IRS-proteins mediate the inhibition of caspase-3 cleavage (Fig. 6B) . However, BAX expression was unaltered in IRS-1-and IRS-2 overexpressing cells compared to EV and untransfected SHSY5Y cells. Thus, increased BAD phosphorylation might prevent glucose-induced caspase-3 activation in IRS-1 and IRS-2 overexpressing cells.
MnSOD expression is increased in IRS-1/-2 overexpressing human neuroblastoma cells
Several defense mechanisms to oxidative stress have been described, reaching from expression of SODs (superoxide dismutases) to activation of the glutathione cycle. In aortic endothelial cells high glucose levels cause cell damage via increased ROS production. Overexpression of the mitochondrial MnSOD nearly completely prevents ROS generation suggesting that MnSOD might also be involved in prevention of glucose neurotoxicity [9] . We therefore investigated the expression of Cu/ZnSOD (SOD1) and MnSOD (SOD2) under basal conditions and 250 mM glucose treatment for 6 h in EV and IRS-protein overexpressing cells. Cu/ZnSOD expression was not changed under basal conditions compared to 250 mM glucose treatment in EV cells (Fig. 7A) . Furthermore, the expression of Cu/ ZnSOD was similar in IRS-1 and IRS-2 overexpressing cells compared to EV cells under basal conditions and glucose treatment (Fig. 7A) . In contrast, MnSOD expression was significantly increased in IRS-1 and IRS-2 overexpressing in comparison to EV cells (Fig. 7B ) but did not further increase or change in response to glucose challenge (Fig. 7A) . Thus, IRS-protein overexpression causes increased MnSOD levels (Fig. 7B ) independent of glucose treatment revealing a second possible mechanism to defend cellular stress caused by increased glucose burden.
FoxO is not involved in mediating the anti-apoptotic effect of IRS-proteins in the context of glucose neurotoxicity
The mammalian forkhead box-O (FoxO) transcription factor family contains at least 4 members. FoxO1, FoxO3a and FoxO6 are expressed in the mammalian CNS. FoxO transcription factors are negatively regulated by the IR/IGF-1R signaling cascade. Upon Akt activation, FoxOs get phosphorylated and form heterodimers with 14-3-3 triggering their nuclear export and degradation. In peripheral tissues, FoxO1 regulated Fig. 6 . BAD, Bim, BAX expression and BAD phosphorylation in IRS-1 and IRS-2 overexpressing cells. A) EV, IRS-1 and IRS-2 overexpressing cells were cultured in DMEM and 10% FCS to 80% confluence, serum starved for 4 h, treated with 0 or 250 mM glucose for 6 h. Glucose treated cells were additionally incubated with 20 μM LY294002 or 50 μM PD98,059 prior to glucose addition. Antibodies detecting BimEL, BimL and BimS were used for Western blots. B) EV, IRS-1 and IRS-2 overexpressing cells were cultured in DMEM and 10% FCS to 80% confluence. Cells were lysed. SDS-PAGE and Western blots were performed as described in Materials and methods. Primary antibodies against pBAD Ser136 , BAD, BAX and actin were used. and actin were performed as described in Materials and methods. B) EV, IRS-1 and IRS-2 overexpressing cells were cultured in DMEM and 10% FCS to 80% confluence, lysed and cell lysates were subject to SDS-PAGE and Western blots using antibodies against MnSOD and actin as loading control. To quantify changes in optical density, we used the software AIDA 4.00.027 (Raytest, Straubenhardt, Germany). Results were expressed as fold increase compared to untreated EV cells. *p ≤ 0.05 unpaired Student's t-test.
genes are involved in glucose metabolism, cell cycle and defense to oxidative stress (e.g., regulation of MnSOD expression). In order to investigate the role of FoxO1 in this context we generated a FoxO1 mutant missing the transactivation domain, and therefore acting as dominant negative (DN), mimicking increased insulin/IGF-1 signaling (Fig. 8A) . This mutant was cloned into pCMV-FLAG 2C and stably transfected into SHSY5Y, as described above. Western blots using antibodies against FoxO1 proved FoxO1DN expression (Fig. 8B) . Two FoxO1DN expressing clones were used for further experiments. We exposed FoxO1DN expressing cells to 250 mM glucose and mannitol for 6 h and performed Western blot analysis to detect caspase-3 cleavage. However, there were no differences in caspase-3 activation between DN expressing, EV and untransfected SHSY5Y cells (Fig. 8B) , suggesting that FoxO1 is not involved in IRS-1/-2-mediated protection from high glucose concentration.
Discussion
Insulin and IGF-1 strongly promote neuronal survival in response to different stressors [25, 26] . IGF-1 and insulin activate Akt to induce BAD phosphorylation and its association with 14-3-3 to release and activate Bcl-2 [19, 24] and inhibit BAX-induced caspase-3 cleavage and apoptosis.
It is not known whether different IRS-proteins exert differential effects on cell survival. In 32D cells expressing IRs and either IRS-1, -2, -3 or −4, Uchida and co-workers [27] showed that IR and IRS-1 or -2 expressing 32D cells mediate intracellular signaling and insulin's antiapoptotic effects equally. However, only IRS-4 seems to be less effective [27] . Our group showed that the lack of either IRS-2 or IRS-1 did not reduce survival of cultured cerebellar granule cells. Furthermore, IGF-1 or BDNF prevented apoptosis in cerebellar granule cells lacking IRS-1 or IRS-2. Thus, IRS-1 and IRS-2 might be exactly redundant regarding IGF-1-mediated anti-apoptosis in neurons, or other IGF-1-mediated signals might be involved [28] .
Interestingly, recent data suggest that IRS-2, but not IRS-1 mediates inhibition of caspase-3 activation and apoptosis due to high glucose levels in neuroblastoma cells. Furthermore, IRS-1 seemed to transmit IGF-1-induced Akt phosphorylation to less extent compared to IRS-2, at least in certain neuronal cell lines, e.g. SH-EP cells [22] . Even though IRS-1 and IRS-2 are almost similar in structure and function [29] the phenotypes of the according knockout mice are rather different [30] [31] [32] , suggesting that the abundance of the different IRS-proteins might play a critical role in mediating the intracellular effects of insulin and IGF-1 [33, 34] . Therefore, it has been argued that differential degradation of IRS-1 and IRS-2 due to high glucose levels largely contributes to their distinct role in mediation of the anti-apoptotic response to glucose challenge in neurons [22] .
Although we could reproduce the previously described data on degradation of IRS-2 and IRS-1 after glucose treatment (data not shown), 10 nM IGF-1 still induced Akt phosphorylation in EV as well as in IRS-1 and IRS-2 overexpressing cells, suggesting that glucose treatment does not cause significant IGF-1 resistance in SHSY5Y cells, and that degradation of the different IRS-proteins is of minor importance in this context. Even an approximately 75% siRNAmediated knockdown of IRS-2 in SHSY5Y cells which transmit IGF1s intracellular signaling mainly via IRS-2 does not reduce but increase Akt phosphorylation. Our data suggest that reduced IRS-2 expression triggers a compensatory mechanism at least partially via IRS-1 expression.
Previous reports suggest that IGF-1 and insulin activate Akt to promote BAD phosphorylation and 14-3-3 binding leading to Bcl-2 activation [17, 24] and inhibition of BAX-induced caspase-3 cleavage and apoptosis in response to different stressors. The experiments of the current study support this as a major mechanism-how IGF-1 inhibits caspase-3 activation following glucose challenge. Accordingly, we observed robustly increased BAD phosphorylation in IRS-1 and IRS-2 overexpressing cells compared to EV and untransfected SHSY5Y cells. Our data strongly suggest that both, IRS-1 and IRS-2, have comparable efficacy to inhibit caspase-3 activation due to glucose neurotoxicity.
FoxO transcription factors act as downstream target of the insulin/ IGF-1 cascade which down-regulates FoxO activity via Akt mediated phosphorylation, in turn triggering nuclear exclusion and degradation of the FoxO transcription factors. There are four different members of the mammalian FoxO-family: FoxO1, FoxO3a, FoxO4 and FoxO6. Apart from FoxO6, which is exclusively expressed in the brain, and FoxO4, which has not been found in the brain [35, 36] , FoxO transcription factors are found ubiquitously. Because of the shared DNA-binding domain, FoxOs are expected to bind to similar DNA sequences [37] . Thus, all FoxOs might be able to regulate the same set of genes through binding to this sequence. Indeed, large overlap in gene expression is observed when comparing the transcriptional activity during overexpression of the individual FoxOs. Functional specificity is likely to be achieved via interaction with co-regulators [38] , suggesting that our FoxO1 mutant (DN) inhibits not only FoxO1-mediated transcription but interferes also with the other FoxOs. Our approach using the FoxO1DN mutant to inhibit FoxO-mediated transcription has been successfully used in previous studies and is well characterized [39, 40] . In neurons, it has been shown that under certain conditions Akt promotes cell survival via termination of FoxOmediated transcription of e.g., Fas-ligand [17] . Our experiments revealed no effect of the FoxO1DN mutant on glucose-induced caspase-3 activation suggesting that in the case of glucose neurotoxicity, inhibition of FoxO-mediated transcription is not involved in the protective effect of IRS-protein-overexpression.
The molecular mechanism of glucose-induced cellular damage is increased oxidative stress. In the presence of hyperglycemia, glucose is processed not only via glycolysis but also via the polyol pathway consuming NADPH. This affects the capacity of glutathione peroxidase to metabolize hydrogen peroxide and causes dysfunction of the respiratory chain leading to increased free-radical levels [1, 41] . In aortic endothelial cells and in retinal cells high glucose levels lead to increased ROS production. Overexpression of the mitochondrial MnSOD nearly completely prevented ROS accumulation suggesting that MnSODs antagonize glucose toxicity [9, 42] . MnSOD is known to be negatively regulated via the IR/IGF-1R signaling pathway in peripheral tissues [40] . We therefore investigated MnSOD and Cu/ZnSOD in our cell lines. Surprisingly, MnSOD but not Cu/ZnSOD is up-regulated in IRS-1 and IRS-2 overexpressing cells compared to EV and untransfected SHSY5Y cells providing a further and new molecular mechanism on how IRS-proteins prevent glucose neurotoxicity. Our results suggest that MnSOD is differently regulated in neurons compared to peripheral tissues since IR/IGF-1R signaling via IRS-proteins leads to increased MnSOD expression in our SHSY5Y cells [40] .
In summary, the present study shows that both IRS-1 and IRS-2 prevent caspase-3 activation induced by hyperglycemia to similar extent. IRS-1 and IRS-2 overexpression leads to increased BAD phosphorylation to prevent caspase-3 cleavage reinforcing the protective role of IGF-1R/IRS/Akt signaling in glucose neurotoxicity. Overexpression of IRS-1 and IRS-2 increases MnSOD expression suggesting that in contrast to peripheral tissues MnSOD is positively regulated via the IR/IGF-1 signaling pathway in neurons providing a new molecular mechanism of cellular protection against high glucose levels mediated by IRS-proteins.
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